Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase kinase kinase 8 |
---|
Ligand | BDBM50191680 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1613130 (CHEMBL3854930) |
---|
IC50 | 3500±n/a nM |
---|
Citation | Glatthar, R; Stojanovic, A; Troxler, T; Mattes, H; Möbitz, H; Beerli, R; Blanz, J; Gassmann, E; Drückes, P; Fendrich, G; Gutmann, S; Martiny-Baron, G; Spence, F; Hornfeld, J; Peel, JE; Sparrer, H Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors. J Med Chem59:7544-60 (2016) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase kinase kinase 8 |
---|
Name: | Mitogen-activated protein kinase kinase kinase 8 |
Synonyms: | C-COT | COT | COT proto-oncogene serine/threonine-protein kinase | Cancer Osaka thyroid oncogene | ESTF | M3K8_HUMAN | MAP3K8 | Tpl-2 | Tumor Progression Loci-2 Kinase (COT) | Tumor progression locus 2 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 52916.89 |
Organism: | Homo sapiens (Human) |
Description: | P41279 |
Residue: | 467 |
Sequence: | MEYMSTGSDNKEEIDLLIKHLNVSDVIDIMENLYASEEPAVYEPSLMTMCQDSNQNDERS
KSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGR
YQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVE
IQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKG
LDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVIL
CRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPG
MRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSALLERKRLLSRKELELP
ENIADSSCTGSTEESEMLKRQRSLYIDLGALAGYFNLVRGPPTLEYG
|
|
|
BDBM50191680 |
---|
n/a |
---|
Name | BDBM50191680 |
Synonyms: | CHEMBL3981321 |
Type | Small organic molecule |
Emp. Form. | C21H19N7 |
Mol. Mass. | 369.4225 |
SMILES | C1CCN(CC1)c1cc2c3n(cnc3cnc2cn1)-c1ccc2nc[nH]c2c1 |
Structure |
|